In vitro assessment of Taxol for human glioblastoma: Chemosensitivity and cellular locomotion

D. L. Silbergeld, M. R. Chicoine, C. L. Madsen

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Although the antineoplastic efficacy of Taxol against a variety of tumors has been established, it has only recently been used for malignant brain tumors. We evaluated in vitro chemosensitivity of glioblastoma to Taxol and the affect of Taxol on glioblastoma cell locomotion. The clonogenic assay was used to evaluate the chemosensitivity of five human glioblastomas and the C6 rat glioma. Cells exposed to Taxol (0-250 nM) were suspended in agar in capillary tubes. Following incubation, colonies were counted to determine percent survival. All six cell lines demonstrated sensitivity to Taxol (LD50 1 nM to >250 nM). However, even at concentrations exceeding those achievable clinically, all cell lines had surviving cells, indicating a saturation threshold for Taxol cytotoxicity. Cell locomotion was evaluated using the radial dish assay to determine the rate of egress of cells from a region of high cell density to the periphery. Increasing Taxol concentration caused increased locomotion in all six cell lines (p < 0.0001). Although Taxol has significant cytocidal impact, it increases in vitro locomotion of glioblastoma cells. These findings suggest that the clinical use of Taxol for glioblastoma may slow the growth of bulk disease, but may also lead to increased tumor invasion.

Original languageEnglish
Pages (from-to)270-276
Number of pages7
JournalAnti-Cancer Drugs
Volume6
Issue number2
DOIs
StatePublished - 1995

Keywords

  • Cell locomation
  • Chemosenitivity
  • Glioblastoma
  • Motility
  • Taxol

Fingerprint

Dive into the research topics of 'In vitro assessment of Taxol for human glioblastoma: Chemosensitivity and cellular locomotion'. Together they form a unique fingerprint.

Cite this